跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Gleezine - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Gleezine
Approved
STANDARD
Gleezine
Azarias Pharmaceutical Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
433e591e88ea9bae
Company
Azarias Pharmaceutical Laboratories Inc.
Type
Standard
Approval Details
Approval Id
433e591e88ea9bae
Drug Approval Philippines Name
Gleezine
Product Name
Gleezine
Registration Number
DRP-4067-04
Brand Name
Gleezine
Generic Name
Cetirizine Hydrochloride
Dosage Form
Syrup (Oral Drops)
Dosage Strength
2.5 mg/mL
Manufacturer
Azarias Pharmaceutical Laboratories Inc.
Distributor
GSP Enterprises
Issuance Date
24 October 2022
Expiry Date
19 October 2028
Pharmacologic Category
Antihistamine (Piperazine derivative)
Classification
Over-the-Counter (OTC) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
433e591e88ea9bae
Type
Standard
Back to Philippines FDA Approvals